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Summary
 
Macrophages can respond to a variety of infectious and/or inflammatory stimuli by secreting an
array of proinflammatory cytokines, the overproduction of which can result in shock or even
death. In this report, we demonstrate that ligation of macrophage Fc
 
g
 
 receptors (Fc
 
g
 
R) can
lead to a reversal of macrophage proinflammatory responses by inducing an upregulation of in-
terleukin (IL)-10, with a reciprocal inhibition of IL-12 production. IL-10 upregulation was
specific to Fc
 
g
 
R ligation, since the ligation of the Mac-1 receptor did not alter IL-10 produc-
tion. The identification of the specific Fc
 
g
 
R subtype responsible for IL-10 upregulation was
determined in gene knockout mice. Macrophages from mice lacking the FcR 
 
g
 
 chain, which is
required for assembly and signaling by Fc
 
g
 
RI and Fc
 
g
 
RIII, failed to upregulate IL-10 in re-
sponse to immune complexes. However, mice lacking either the Fc
 
g
 
RII or the Fc
 
g
 
RIII were
fully capable of upregulating IL-10 production, implicating Fc
 
g
 
RI in this process. The biolog-
ical consequences of Fc
 
g
 
RI ligation were determined in both in vitro and in vivo models of in-
flammation and sepsis. In all of the models tested, the ligation of Fc
 
g
 
R promoted the produc-
tion of IL-10 and inhibited the secretion of IL-12. This reciprocal alteration in the pattern of
macrophage cytokine production illustrates a potentially important role for Fc
 
g
 
R-mediated
clearance in suppressing macrophage proinflammatory responses.
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acrophages are prodigious secretory cells which can
produce a number of molecules that can either po-
tentiate or dampen immune responses (1). In response to
infectious or inflammatory stimuli, macrophages can pro-
duce several proinflammatory molecules, including IL-12,
TNF-
 
a
 
, IL-6, and IL-1 (1, 2). These proinflammatory
molecules are important for host defense, because experi-
mentally infected animals deficient in these cytokines are
more susceptible to acute bacterial infections than are nor-
mal animals (3, 4). However, the production of proinflam-
matory cytokines must be tightly regulated, since their pro-
duction is also correlated with many of the pathologies
associated with acute sepsis or with autoimmune diseases.
Macrophages themselves can participate in this regulation
by the production of antiinflammatory molecules. The
secretion of prostaglandins, TGF-
 
b
 
, and IL-10 by macro-
phages has been associated with antiinflammatory responses.
Thus, the balance between the secretion of pro- and anti-
inflammatory molecules by macrophages is a critical com-
ponent of the acute phase response and has the potential to
affect the adaptive immune response that subsequently de-
velops.
IL-10 has been associated with the inhibition of Th1-
type immune responses. IL-10 has been shown to inhibit
the production of Th1 cytokines and to decrease the prolif-
eration of Th1 cells to antigen (5, 6). The administration of
exogenous IL-10 can diminish the toxicity of LPS (7). IL-10
has macrophage-deactivating effects and can inhibit the
production of IL-12 by macrophages (8, 9). It is now well
established that IL-12 plays an important role in the devel-
opment of Th1-type immune responses (2). This cytokine
is a potent inducer of IFN-
 
g
 
 from T and NK cells, and has
been shown to play a crucial role in the development of
immunity to intracellular pathogens (10, 11).
In this study, we examine the production of IL-10 and
IL-12 by macrophages and the influence that phagocytic
receptor ligation can exert on this production. We demon-
strate that the ligation of Fc
 
g
 
RI can enhance the produc-
tion of IL-10, reversing the proinflammatory response of mac-
rophages to stimuli such as bacteria or bacterial products.
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Materials and Methods
 
Mice and Macrophages.
 
6–8-wk-old BALB/c and C57BL/6
mice were obtained from Taconic Farms, Inc. (Germantown,
NY). FcR 
 
g
 
 chain–deficient (FcR
 
g
 
2
 
/
 
2
 
) and Fc
 
g
 
RII
 
2
 
/
 
2
 
 mice
(12, 13) were provided by Dr. Jeffrey Ravetch (The Rockefeller
University, New York). Fc
 
g
 
RIII
 
2
 
/
 
2
 
 mice (14) were provided by
Dr. J. Sjef Verbeek (University Hospital Utrecht, Utrecht, The
Netherlands). Bone marrow–derived macrophages (BMM
 
f
 
) were
established as described previously (15).
 
Opsonized Erythrocytes.
 
IgG-opsonized sheep erythrocytes (E-IgG)
were generated by incubating SRBC (Lampire Biological Labo-
ratories, Pipersville, PA) with rabbit anti-SRBC IgG (Organon
Teknika-Cappel, Durham, NC) at nonagglutinating titers for 40
min at room temperature. E-IgG were washed and resuspended
in HBSS (GIBCO BRL, Gaithersburg, MD) before their addi-
tion to macrophages. Complement-opsonized erythrocytes (E-
C3bi) were generated by incubating SRBC with culture superna-
tants of hybridoma S-S.3 (anti-SRBC IgM/
 
k
 
; American Type
Culture Collection, Rockville, MD) at nonagglutinating titers for
40 min at room temperature. IgM-opsonized erythrocytes were
washed twice with HBSS and resuspended at 10
 
8
 
 cells/ml in
HBSS with 10% murine C5–deficient serum. After a 15-min in-
cubation at 37
 
8
 
C, E-C3bi were washed and resuspended in HBSS
before their addition to macrophages. Erythrocytes were added to
macrophage monolayers at a ratio of 20:1.
 
Macrophage Stimulation.
 
BMM
 
f
 
 monolayers were stimulated
with LPS (
 
Escherichia coli
 
 0127:B8; Sigma Chemical Co., St.
Louis, MO) at a final concentration of 100 ng/ml, in the presence
or absence of opsonized erythrocytes. Cytokine levels in cell su-
pernatants were measured by ELISA 24 h after the addition of
stimuli. For mRNA analysis, cells were harvested 6 h after the ad-
dition of stimuli, and cytokine mRNA levels were determined by
reverse transcription (RT)-PCR, as described previously (15). In
some instances, macrophages were stimulated with heat-killed
bacteria. The 
 
Eagan
 
 clinical isolate of type b 
 
Haemophilus influen-
zae
 
 has been described and characterized previously (16). Organ-
isms were grown for 3 h at 37
 
8
 
C in brain–heart infusion broth
(Difco Laboratories Inc., Detroit, MI) supplemented with NAD
and hemin and then washed twice in HBSS. Bacteria were heat
killed by incubating at 60
 
8
 
C for 15 min. Bacteria were opsonized
by incubation with anti–
 
H. influenzae
 
 polyserotype antiserum
(Difco Laboratories Inc.) at a 1:25 dilution for 15 min at room
temperature. IgG-opsonized or unopsonized bacteria were added
to monolayers of BMM
 
f
 
, at a ratio of 130 bacteria per macro-
phage. Cytokine levels in cell supernatants were measured by ELISA
24 h after the addition of bacteria. In some studies, cytokine pro-
duction induced by LPS or IgG-LPS was examined. IgG-LPS
was generated by incubating LPS (
 
E. coli
 
 0128:B12, 100 
 
m
 
g/ml;
Sigma Chemical Co.) with rabbit anti-LPS polyclonal antiserum
(Calbiochem-Novabiochem, San Diego, CA) at a 1:1 dilution for
15 min at 4
 
8
 
C. For in vitro studies, LPS or IgG-LPS was added to
monolayers of BMM
 
f
 
 at a final LPS concentration of 100 ng/ml.
For in vivo challenge studies, recombinase-activating gene
(RAG)-1
 
2
 
/
 
2
 
 mice (The Jackson Laboratory, Bar Harbor, ME)
received either IgG-LPS or LPS intravenously (tail vein) at a final
LPS dose of 4 
 
m
 
g per mouse. Control LPS was incubated with an
equal volume of HBSS. Mice were bled by retroorbital puncture
at the indicated time intervals, and serum cytokine levels were
determined by ELISA.
 
Cytokine ELISAs.
 
Levels of murine cytokines were measured
by ELISA using appropriately diluted culture supernatants or se-
rum. IL-10 concentrations were determined with a mouse IL-10
ELISA kit (Genzyme Corp., Cambridge, MA, or Biosource In-
ternational, Camarillo, CA) according to the manufacturer’s in-
structions. Murine IL-12(p40) levels were measured with a
mouse IL-12 ELISA kit (Biosource International) according to
the manufacturer’s instructions. Murine IL-12(p70) levels were
measured by ELISA using mAbs C18.2 (anti–murine IL-12 p35)
and C17.15 (biotinylated anti–murine IL-12 p40) as ELISA cap-
ture and detection antibodies, respectively, according to protocols
provided by PharMingen (San Diego, CA). Recombinant murine
IL-12 (Genzyme Corp.) was used as a standard. mAbs C18.2 and
C17.15 were purified from ascitic fluid provided by Dr. Giorgio
Trinchieri (The Wistar Institute, Philadelphia, PA).
 
Results
 
Effect of Fc
 
g
 
R Ligation on Macrophage IL-10 Production.
 
The production of IL-10 by BMM
 
f
 
 was examined after
specific receptor ligation. BMM
 
f
 
 were stimulated either
with LPS alone, or with LPS in the presence of erythro-
cytes opsonized with either IgG or complement. The addi-
tion of LPS to monolayers of BMM
 
f
 
 induced a modest
but significant production of IL-10 by macrophages. How-
ever, the ligation of Fc
 
g
 
R simultaneously with the addition
of LPS enhanced markedly the production of IL-10. This
enhancement was observed at both the mRNA (Fig. 1 
 
A
 
)
and protein (Fig. 1 
 
C
 
) levels. IL-10 mRNA was increased
by four- to eightfold (Fig. 1 
 
B
 
), and protein secretion was
increased by greater than sixfold after Fc
 
g
 
R ligation (Fig. 1
 
C
 
). The induction of IL-10 was specific to the Fc
 
g
 
R, be-
cause ligation of macrophage complement receptors did
not significantly alter IL-10 mRNA (Fig. 1 
 
A
 
) or protein
(Fig. 1 
 
C
 
) production. The ligation of macrophage Fc
 
g
 
R
or complement receptors in the absence of LPS was not
sufficient to induce the production of notable levels of IL-10
(Fig. 1 
 
C
 
, 
 
inset
 
).
 
Effect of Fc
 
g
 
R Ligation on IL-10 Production in Macrophages
from Gene Knockout Mice.
 
To determine the Fc
 
g
 
R sub-
type responsible for IL-10 upregulation, BMM
 
f
 
 from gene
knockout mice were studied. The FcR 
 
g
 
 chain is an essen-
tial component of both the Fc
 
g
 
RI and Fc
 
g
 
RIII, and is re-
quired for both receptor assembly and signaling (12). Mac-
rophages from mice lacking the common 
 
g
 
 chain (FcR
 
g
 
2
 
/
 
2
 
)
failed to upregulate IL-10 production in response to E-IgG
(Fig. 2), implicating one of these two receptors in this phe-
nomenon. Macrophages derived from mice lacking either
the Fc
 
g
 
RII or the Fc
 
g
 
RIII were fully capable of upregulat-
ing IL-10 production in response to E-IgG (Fig. 2). These
results are consistent with the high affinity Fc
 
g
 
RI being the
mediator of IL-10 induction.
 
Macrophage-derived IL-10 Can Suppress the Production of
IL-12.
 
Studies were undertaken to determine whether
the amount of IL-10 produced by macrophages in response
to Fc
 
g
 
R ligation was adequate to suppress IL-12 produc-
tion. Macrophages were stimulated with LPS in the pres-
ence of Fc
 
g
 
R ligation for 24 h. Supernatants from these
monolayers were collected and assayed for their ability to
inhibit IL-12 production. Monolayers of BMM
 
f
 
 were
primed with IFN-
 
g
 
 and then stimulated with LPS in the 
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presence or absence of a 33% supernatant from LPS/Fc
 
g
 
R-
stimulated macrophages. 24 h after this stimulation, the
production of IL-12(p70) was measured by ELISA. The su-
pernatants from LPS/Fc
 
g
 
R-stimulated BMM
 
f
 
 reduced
IL-12(p70) secretion to background levels (Fig. 3). Treat-
ing these inhibitory supernatants with a neutralizing mAb
to IL-10 partially restored IL-12(p70) production. These
results indicate that the IL-10 produced by macrophages af-
ter LPS/Fc
 
g
 
R stimulation is adequate to inhibit the pro-
duction of IL-12 by IFN-
 
g
 
–primed macrophages.
 
Modulating Macrophage Proinflammatory Responses by Ligat-
ing Fc
 
g
 
R.
 
Cytokine production by macrophages in re-
sponse to potential proinflammatory stimuli was examined
after Fc
 
g
 
R ligation. IL-10 and IL-12(p40) levels were mea-
sured by ELISA 24 h after the addition of either LPS or
IgG-opsonized LPS to BMM
 
f
 
. As expected, LPS induced
a potent proinflammatory response by macrophages, char-
acterized by moderate levels of IL-10 (Fig. 4 
 
A
 
) and high
levels of IL-12(p40) (Fig. 4 
 
B). In contrast to this, IgG-
opsonized LPS induced higher levels of IL-10 and only
modest levels of IL-12(p40). Similar studies were performed
using the Gram-negative bacterium, H. influenzae. Cyto-
kine production by macrophages in response to unop-
sonized heat-killed type b H. influenzae was compared with
that induced in response to IgG-opsonized heat-killed bac-
Figure 1. FcgR ligation enhances LPS-induced
IL-10 production. (A) BMMf were exposed to ei-
ther LPS alone or LPS in combination with either
E-IgG or E-C3bi. 6 h after the addition of stimuli,
total RNA was isolated and used to carry out com-
petitive RT-PCR. Input cDNAs were adjusted to
yield comparable ratios of competitor (upper band in
each reaction) to wild-type (lower band in each re-
action) intensities for the amplification reaction for
hypoxanthine-guanine phosphoribosyltransferase
(HPRT), as resolved on a 2% ethidium-stained aga-
rose gel. The adjusted input cDNAs were then used
in subsequent RT-PCR reactions using primers for
IL-10. Results are representative of two separate
experiments. (B) cDNA generated from BMMf ex-
posed to LPS or LPS in combination with E-IgG,
were first normalized for HPRT levels. Constant
volumes of normalized cDNAs were then ampli-
fied in the presence of increasing concentrations of
competitor (PQRS), using primers for IL-10. The
concentration of the experimental cDNA is repre-
sented by the equivalent intensities of competitor
and wild-type bands. The fold increase in IL-10 levels between BMMf exposed to LPS or LPS in combination with E-IgG can be determined by taking
the ratio of their equivalence points. (C) BMMf were exposed to either media, LPS, E-IgG, or E-C3bi (inset), or LPS alone or LPS in combination with
either E-IgG or E-C3bi. After 24 h, the supernatant was harvested, and IL-10 levels were determined by ELISA. Values represent the mean of three inde-
pendent experiments, each performed in triplicate, 6SE.
Figure 2. FcgRI is responsible for the FcgR-mediated enhancement of
IL-10 production. BMMf from C57BL/6, FcRg2/2, FcgRII2/2, or
FcgRIII2/2 mice were exposed to LPS alone or LPS in combination with
either E-IgG or unopsonized erythrocytes (E). After 24 h, the supernatant
was harvested, and IL-10 levels were determined by ELISA. Determina-
tions were performed in triplicate, and values are expressed as the means
6 SD. Results are representative of three separate experiments.
Figure 3. IL-10 produced by
macrophages stimulated with
LPS/FcgR can suppress IL-12
production. Supernatants from
BMMf exposed to either media
alone or LPS in combination with
E-IgG for 24 h were harvested
and filtered through a 0.2-mm
filter. Supernatants were diluted
1:3 with media and incubated for
15 min at 48C in either the pres-
ence or absence of a neutralizing
mAb to IL-10 (JESS-2A5; 20
mg/ml). Diluted supernatants were then added to BMMf that had been
primed with IFN-g (100 U/ml) for 8 h, and immediately treated with
LPS. After 24 h, the supernatant was harvested, and IL-12(p70) levels
were determined by ELISA. Values represent the mean of three indepen-
dent experiments, each performed in triplicate, 6SE.220 FcgR-mediated Production of IL-10
teria. Unopsonized H. influenzae induced the production of
relatively high levels of both IL-10 (Fig. 4 C) and IL-
12(p40) (Fig. 4 D). However, IgG-opsonized bacteria in-
duced a significant decrease in the production of IL-12(p40)
protein and an increase in the production of IL-10. Thus,
in both in vitro models, the ligation of FcgR by opsoniza-
tion with IgG resulted in a reduction in macrophage proin-
flammatory responses.
Modulation of In Vivo Responses to Bacterial Endotoxin.
Studies similar to the in vitro studies performed above were
repeated in experimental animals. Several groups have
demonstrated that the administration of LPS to experimen-
tal animals results in the rapid production of proinflamma-
tory cytokines (17). Given our in vitro observations, we
sought to determine whether IgG opsonization of LPS
could reverse the inflammatory cytokine response to LPS
in vivo. These studies were performed in RAG-12/2 mice,
since recent studies have demonstrated that normal mice
have naturally occurring antibodies to LPS (18). Mice were
injected with either LPS or IgG-LPS, and the generation of
cytokines in serum was analyzed over the ensuing 24 h.
The injection of low levels (4 mg) of LPS into RAG-12/2
mice induced the transient production of relatively high
levels of serum IL-12(p40) (Fig. 5 A) and only modest lev-
els of IL-10 (Fig. 5 B). The observation that RAG-12/2
mice make high amounts of IL-12 in response to low levels
of LPS is consistent with previous observations that anti-
body-deficient mice are hypersusceptible to LPS (18). The
injection of IgG-opsonized LPS into these mice induced an
alteration in the cytokine profile. RAG-12/2 mice injected
with IgG-LPS made only modest levels of IL-12(p40) (Fig. 5
A), but they more than doubled their production of IL-10
(Fig. 5 B). This reciprocal alteration in the pattern of cy-
tokine production suggests that IgG opsonization of LPS
not only increases the rate of LPS clearance through FcgR,
but in doing so also mediates a desirable effect by dampen-
ing the proinflammatory response to LPS.
Discussion
Monocytes and macrophages are a primary source of IL-12.
IL-12 is a potent inducer of cell-mediated immune re-
sponses, and animals lacking IL-12 are invariably more sus-
ceptible to infections with intracellular pathogens (2). Be-
cause IL-12 plays such a central role in the development of
Th1-type immune responses, we have begun to examine
the regulation of IL-12 production in macrophages. We
have described previously a mechanism whereby receptor
ligation can downmodulate IL-12 production by macro-
Figure 4. The modulation of
inflammatory response by FcgR
ligation. BMMf were exposed
to either media, LPS, or IgG-
LPS (A and B). After 24 h, the
supernatant was harvested, and
IL-10 (A) and IL-12(p40) (B)
levels were determined by ELISA.
Determinations were performed
in triplicate, and values are ex-
pressed as the means 6 SD. Re-
sults are representative of four sep-
arate experiments. BMMf were
incubated with media alone or
with equal numbers of either un-
opsonized or IgG-opsonized H.
influenzae (C and D). After 24 h,
the supernatant was harvested,
and IL-10 (C) and IL-12(p40)
(D) levels were determined by
ELISA. Determinations were
performed in triplicate, and val-
ues are expressed as the means 6
SD. Results are representative of
three separate experiments.
Figure 5. Production of IL-12(p40)
and IL-10 in a murine model of septic
shock. RAG-12/2 mice received ei-
ther LPS or IgG-LPS intravenously at
a final LPS dose of 4 mg per mouse.
Serum levels of IL-12(p40) (A) and IL-
10 (B) were measured at the indicated
times after challenge. Data show the
mean 6 SD of groups of four sepa-
rately handled mice. *P , 0.01, and
**P , 0.08 (significant by rank–sum
analysis) versus the LPS-treated group
as determined by Student’s t test.221 Sutterwala et al. Brief Definitive Report
phages (15). In this work, we describe a second novel
mechanism of downregulating IL-12. This mechanism is dis-
tinct from the previously described mechanism in several
important ways. First, the present mechanism is not a direct
regulation of IL-12 transcription, but rather depends on the
production of the inhibitory cytokine IL-10. Second, this
regulation is specific to a single receptor class on macro-
phages, the FcgRI. We show that ligating the macrophage
FcgRI increases IL-10 mRNA, resulting in a substantial in-
crease in IL-10 secretion. This macrophage-derived IL-10
is a potent inhibitor of IL-12 production by macrophages.
Even IFN-g–primed macrophages fail to make IL-12 in re-
sponse to LPS when exposed to macrophage supernatants
containing IL-10. Thus, the ligation of the macrophage
FcgRI can downmodulate IL-12 production via a mecha-
nism that is dependent on macrophage-derived IL-10.
In identifying the FcgRI as the macrophage receptor
that upregulates IL-10 production, we can now associate
distinct biological activities with each of the three FcgR
classes. CD16, the FcgRIII, is the prototypical proinflam-
matory Fcg receptor. Ligating FcgRIII has been associated
with the production of proinflammatory cytokines (19),
and mice lacking FcgRIII undergo diminished Arthus re-
actions (14). CD32, the FcgRII, is a negative regulator of
immune complex–triggered immune responses, and mice
lacking FcgRII have augmented anaphylactic responses to
IgG (13). Our studies would classify the FcgRI (CD64) as
another inhibitory FcgR, but by a different mechanism
than that observed for FcgRII. Whereas FcgRII inhibits
signaling (20), FcgRI actively promotes the transcription of
an inhibitory cytokine, IL-10. Thus, by two distinct mech-
anisms, both the FcgRI and FcgRII can inhibit inflamma-
tory responses to immune complexes. Previous observa-
tions that immune complexes can inhibit both the in vivo
clearance of Listeria monocytogenes (21) and the in vitro mac-
rophage tumoricidal and cytotoxic activity (22, 23) are
consistent with FcgR ligation leading to an inhibition of
immune responses.
The in vitro studies presented here indicate that FcgRI
ligation has the potential to dampen the acute response to
inflammatory stimuli such as LPS or Gram-negative bacte-
ria. In both cases, opsonization with IgG increased mac-
rophage IL-10 production and diminished IL-12 produc-
tion. The prediction from these studies is that bacterial
clearance in an immune animal may be associated with a
diminished inflammatory response relative to nonimmune
animals. Furthermore, targeting LPS specifically to FcgRI
might be a practical way of eliminating endotoxin without
the consequent proinflammatory sequelae. The reciprocal
alteration of IL-10 and IL-12 after FcgR ligation also has
the potential to exert an impact on the acquired immune
response, biasing it towards a Th2-type response. The im-
plication from these studies is that IgG itself may be an im-
portant promoter of the Th2-type immune response.
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